>Indeed the policy is essentially as efficient as pricing >organs. Please explain further on this point. Certainly, it is better than the current situation, and the political objections are minimized. But I don't think its efficiency properties rival market efficiency.
Among the participants in the cooperative the organs still remain a common pool. How do you allocate differing body parts? Also, the incentives to provide good organs in this market seems weak. Those with high quality organs benefit much less from this arrangement than in a market. JC
